Serial 79438530

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Sept 2025 filing date already counts against anyone who files later.

Record

Serial number

79438530

Mark type

Design / logo

Filed

25 Sept 2025

Published for opposition

07 Apr 2026

Attorney of record

Maury M. Tepper, III

Goods and services

• Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Owner

• Novartis AG, CH

Prosecution history

• 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 13 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 19 Feb 2026 — REFUSAL PROCESSED BY IB
• 17 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 16 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 16 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 04 Feb 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 04 Feb 2026 — REFUSAL PROCESSED BY MPU
• 07 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 06 Jan 2026 — NON-FINAL ACTION WRITTEN
• 30 Dec 2025 — ASSIGNED TO EXAMINER
• 16 Dec 2025 — APPLICATION FILING RECEIPT MAILED
• 16 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 16 Dec 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
• 04 Dec 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB